de la Fuente-Nunez is a presidential associate professor at the University of Pennsylvania. Skinner is CEO of the AMR Action Fund. Of all the areas of drug development that artificial intelligence has ...

Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers ...

Biosimulation Market Biosimulation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market by Phase, Modality, Application, Indication, End User - Global Forecast to 2031" has been ...

The World Health Organization (WHO) has outlined desired antibacterial characteristics for three priority infections as part of a move to direct research towards developing urgently needed antibiotics ...

Creative Biolabs provides customized support across key stages of lipid-based therapeutic development, helping researchers optimize delivery systems for different types of therapeutic payloads, ...

For decades, the global pipeline for developing new antibiotics has worked in reverse – prioritising the countries least ...

Antibiotics are a crucial tool in the fight against bacterial infections. But the World Health Organization has long warned that we are facing an antibiotic crisis. Bacteria can easily adapt, evolve, ...

Gram-negative bacteria, notorious for their antibiotic resistance, possess a formidable defense mechanism in the form of lipopolysaccharides (LPS). These large molecules, consisting of fatty acyl ...

In this New Scientist CoLab podcast, experts from global life sciences leader Cytiva explain the hidden, high-stakes science ...

Scientists from the University of Tübingen and Monash University studied glycopeptide antibiotics, a key resource in countering drug-resistant pathogens, to uncover their evolutionary origins to gain ...

Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip ...